Trump's Beijing visit and Morgan Stanley's bullish outlook signal a potential rally in Chinese equities. Analysis of catalysts and risks.
Morgan Stanley sets new price targets for Hang Seng, MSCI China, HSCEI, and CSI-300 for 2Q 2027, implying upside of 8%โ12%.